Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B

Clicks: 305
ID: 6021
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #563 of 1,693 articles by views in Infection and drug resistance

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,693 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Poor adherence is a contributor to viral breakthrough in patients with chronic hepatitis B Liguo Wang,1,* Peng Chen,2,* Chao Zheng3 1Department of Infectious Diseases, First Affiliated Hospital of Xiamen University, Fujian Province, China; 2Department of Emergency, Xinglin Hospital, First Affiliated Hospital of Xiamen University, Fujian Province, China; 3Department of Respiratory, First Affiliated Hospital of Xiamen University, Fujian Province, China *These authors contributed equally to this work Objective: The objective of this study was to explore the risk factors of poor adherence of nucleoside analogs (NUC) treatment in chronic hepatitis B (CHB) patients and the virological changes in patients with poor adherence. Subjects and methods: A total of 205 CHB patients were enrolled. The patients’ demographic data and family history were collected. NUC adherence was calculated every 12 weeks as follows: number of NUC tablets taken by the patients was divided by the number of NUC tablets prescribed. NUC adherence > 90% was defined as good adherence of NUC treatment. Results: NUC adherence of male patients was significantly lower than that of female patients. Adherence among patients with previous NUC treatment was poorer than that of patients without previous NUC treatment. Multivariate analysis indicated that female gender (OR
Reference Key
liguo2018poorinfection Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Liguo Wang;Peng Chen;Chao Zheng and
Journal Infection and drug resistance
Year 2018
DOI
10.2147/IDR.S186719
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.